Search Results

There are 10013 results for: content related to: Use of Vasculature-disrupting Agents in Non-Oncology Indications

  1. You have full text access to this OnlineOpen article
    An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate

    British Journal of Pharmacology

    Volume 171, Issue 21, November 2014, Pages: 4902–4913, L J Williams, D Mukherjee, M Fisher, C C Reyes-Aldasoro, S Akerman, C Kanthou and G M Tozer

    Article first published online : 24 OCT 2014, DOI: 10.1111/bph.12817

  2. You have free access to this content
    Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate

    International Journal of Cancer

    Volume 129, Issue 8, 15 October 2011, Pages: 1979–1989, Sarah Jane Lunt, Simon Akerman, Sally A. Hill, Matthew Fisher, Victoria J. Wright, Constantino C. Reyes-Aldasoro, Gillian M. Tozer and Chryso Kanthou

    Article first published online : 13 APR 2011, DOI: 10.1002/ijc.25848

  3. MALDI-MSI and label-free LC-ESI-MS/MS shotgun proteomics to investigate protein induction in a murine fibrosarcoma model following treatment with a vascular disrupting agent

    PROTEOMICS

    Volume 14, Issue 7-8, April 2014, Pages: 890–903, Laura M. Cole, Joanne E. Bluff, Vikki A. Carolan, Martyn N. Paley, Gillian M. Tozer and Malcolm R. Clench

    Article first published online : 1 APR 2014, DOI: 10.1002/pmic.201300429

  4. SELECTIVE TARGETING OF THE TUMOUR VASCULATURE

    ANZ Journal of Surgery

    Volume 78, Issue 11, November 2008, Pages: 955–967, Lie S. Chan, Jurstine Daruwalla and Christopher Christophi

    Article first published online : 21 OCT 2008, DOI: 10.1111/j.1445-2197.2008.04712.x

  5. Imaging the Effects of Vasculature-targeting Agents

    Vascular-Targeted Therapies in Oncology

    Dietmar W. Siemann, Pages: 277–304, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.ch16

  6. Vasculature-disrupting Strategies Combined with Bacterial Spores Targeting Hypoxic Regions of Solid Tumors

    Vascular-Targeted Therapies in Oncology

    G-One Ahn, J. Martin Brown, Pages: 261–276, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.ch15

  7. You have free access to this content
    Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies

    International Journal of Cancer

    Volume 133, Issue 11, 1 December 2013, Pages: 2563–2576, Simon Akerman, Matthew Fisher, Rachel A. Daniel, Diane Lefley, Constantino C. Reyes-Aldasoro, Sarah Jane Lunt, Sheila Harris, Meit Bjorndahl, Leigh J. Williams, Helen Evans, Paul R. Barber, Vivien E. Prise, Borivoj Vojnovic, Chryso Kanthou and Gillian M. Tozer

    Article first published online : 10 JUL 2013, DOI: 10.1002/ijc.28281

  8. You have free access to this content
    Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies

    International Journal of Experimental Pathology

    Volume 90, Issue 3, June 2009, Pages: 284–294, Chryso Kanthou and Gillian M. Tozer

    Article first published online : 11 MAY 2009, DOI: 10.1111/j.1365-2613.2009.00651.x

  9. Colchicine site inhibitors of microtubule integrity as vascular disrupting agents

    Drug Development Research

    Volume 69, Issue 6, September 2008, Pages: 352–358, Ray M. Lee and David A. Gewirtz

    Article first published online : 9 DEC 2008, DOI: 10.1002/ddr.20267

  10. You have free access to this content
    Disrupting established tumor blood vessels

    Cancer

    Volume 116, Issue 8, 15 April 2010, Pages: 1859–1871, Mark J. McKeage and Bruce C. Baguley

    Article first published online : 17 FEB 2010, DOI: 10.1002/cncr.24975

  11. Morphologic Manifestations of Vascular-disrupting Agents in Preclinical Models

    Vascular-Targeted Therapies in Oncology

    Mumtaz V. Rojiani, Amyn M. Rojiani, Pages: 81–94, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.ch5

  12. You have free access to this content
    A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours

    British Journal of Clinical Pharmacology

    Volume 71, Issue 6, June 2011, Pages: 860–870, Xuexin He, Su Li, He Huang, Zhiming Li, Likun Chen, Sheng Ye, Jiajia Huang, Jing Zhan and Tongyu Lin

    Article first published online : 12 MAY 2011, DOI: 10.1111/j.1365-2125.2011.03928.x

    Corrected by:

    Erratum

    Vol. 72, Issue 1, 182, Article first published online: 9 JUN 2011

  13. Vascular disrupting agents

    Journal of Cellular Biochemistry

    Volume 99, Issue 4, 1 November 2006, Pages: 1021–1039, M.J. Pilat and P.M. LoRusso

    Article first published online : 22 AUG 2006, DOI: 10.1002/jcb.20783

  14. MRI & MRS assessment of the role of the tumour microenvironment in response to therapy

    NMR in Biomedicine

    Volume 24, Issue 6, July 2011, Pages: 612–635, Leanne K. Bell, Nicola L. Ainsworth, Shen-Han Lee and John R. Griffiths

    Article first published online : 12 MAY 2011, DOI: 10.1002/nbm.1720

  15. Molecular Recognition of the Colchicine Binding Site as a Design Paradigm for the Discovery and Development of Vascular Disrupting Agents

    Vascular-Targeted Therapies in Oncology

    Dietmar W. Siemann, Pages: 95–121, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.ch6

  16. Clinical Progress in Tumor Vasculature-disrupting Therapies

    Vascular-Targeted Therapies in Oncology

    Andrew M. Gaya, Gordon J. S. Rustin, Pages: 305–322, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.ch17

  17. The Property of Contingent Negative Variation (CNV) in Psychiatric Patients: Schizophrenia and Neurosis

    Psychiatry and Clinical Neurosciences

    Volume 32, Issue 4, December 1978, Pages: 539–552, Yoshihisa Fukui, Michihiko Nakamura, Iwao Kadobayashi and Nobukatsu Katoh

    Article first published online : 17 MAR 2008, DOI: 10.1111/j.1440-1819.1978.tb00161.x

  18. Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels

    ChemMedChem

    Volume 9, Issue 4, April 2014, Pages: 847–854, Katharina Mahal, Dr. Marcus Resch, Prof. Dr. Ralf Ficner, Prof. Dr. Rainer Schobert, Dr. Bernhard Biersack and Dr. Thomas Mueller

    Article first published online : 23 FEB 2014, DOI: 10.1002/cmdc.201300531

  19. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  20. You have free access to this content
    Index

    Vascular-Targeted Therapies in Oncology

    Dietmar W. Siemann, Pages: 341–350, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.index